Similar Articles

NLRP3 Inflammasome: A New Target in Psychiatric Disorders

Sevda Çelik, Aylin Kayaaltı, Oytun Erbaş

DOI: 10.5606/jebms.2021.75681

Issue: 2021, Volume 2 - Issue 3
2233 1139

Glutamate Receptor Activity in Neuropsychiatric Disorders

Damla Koyun, Merve Nur Sevinç, İlknur Altuntaş, Oytun Erbaş

DOI: 10.5606/jebms.2022.1009

Issue: 2022, Volume 3 - Issue 1
1246 794

Understanding the Role of DISC1 in Psychiatric Disorders

Şeyda Yazıcı, Hadi Sasani, Oytun Erbaş

DOI: 10.5606/jebms.2022.1011

Issue: 2022, Volume 3 - Issue 1
2543 938

Human Prefrontal Cortex: Regions and Functions

Ece Sarı, Oytun Erbaş

DOI: 10.5606/jebms.2022.1020

Issue: 2022, Volume 3 - Issue 2
5419 1860

Evidence for Genetic Relationships in Attention-Deficit Hyperactivity Disorder

Büşra Candan Balkan, Kerem Can Tunç, Oytun Erbaş

DOI: 10.5606/jebms.2022.1036

Issue: 2022, Volume 3 - Issue
1119 865

Non-Coding RNAs in Brain Function and Disorders

Buse Kaptan, Mai Abusalim, Oytun Erbaş

DOI: 10.5606/jebms.2023.1042

Issue: 2023, Volume 4 - Issue 1
923 836

Endoplasmic Reticulum Stress: Implications for Psychiatric Disorders

Ecren Büyükada, Ejder Saylav Bora, İlknur Altuntaş, Oytun Erbaş

DOI: 10.5606/jebms.2023.1044

Issue: 2023, Volume 4 - Issue 1
1375 769

Exploring Neuroplasticity: The Role of LSD, Methamphetamine, Cannabis, and Ketamine in Psychiatric Disorders

Uğurcan Altıok, Oytun Erbaş

DOI: 10.5606/jebms.2024.1098

Issue: 2024, Volume 5 - Issue 3
2435 727